Motus GI Holdings, Inc. (MOTS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 25, 2024, 9:30 AM EST
Motus GI Holdings Revenue
Motus GI Holdings had revenue of $64.00K in the quarter ending March 31, 2024, with 14.29% growth. This brings the company's revenue in the last twelve months to $327.00K, down -47.93% year-over-year. In the year 2023, Motus GI Holdings had annual revenue of $319.00K, down -46.11%.
Revenue (ttm)
327.00K
Revenue Growth
-47.93%
P/S Ratio
0.00
Revenue / Employee
21.80K
Employees
15
Market Cap
719.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 319.00K | -273.00K | -46.11% |
| Dec 31, 2022 | 592.00K | 201.00K | 51.41% |
| Dec 31, 2021 | 391.00K | 293.00K | 298.98% |
| Dec 31, 2020 | 98.00K | -9.00K | -8.41% |
| Dec 31, 2019 | 107.00K | 71.00K | 197.22% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Motus GI Holdings News
- 8 months ago - Introducing Motus Protect: Unique Risk Management Solutions for Companies Dependent on Employee-Owned Vehicles - Business Wire
- 10 months ago - Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 months ago - EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer - Business Wire
- 11 months ago - Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds - GlobeNewsWire
- 11 months ago - Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract - GlobeNewsWire
- 11 months ago - Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders - GlobeNewsWire
- 11 months ago - Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation - GlobeNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January - Corcept Therapeutics (NASDAQ:CORT), Kintara Therapeutics (NASDAQ:KTRA) - Benzinga